Seres Therapeutics
MCRB
#8361
Rank
NZ$0.29 B
Marketcap
$1.71
Share price
5.42%
Change (1 day)
-19.64%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.78

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.99. In 2022 the company made an earnings per share (EPS) of -$4.15 a decrease over its 2021 EPS that were of -$1.29.

EPS history for Seres Therapeutics from 2014 to 2023

201620192022-$4-$3-$2-$1$10companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-$1.78-57%
2022-$4.15220.55%
2021-$1.29-34.23%
2020-$1.97-15.27%
2019-$2.32-46.09%
2018-$4.319.95%
2017-$3.92-3.49%
2016-$4.06-10.19%
2015-$4.52321.85%
2014-$1.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.79 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.00 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA